Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Melissa officinalis (lemon balm) is a perennial herb in the mint family (Lamiaceae), native to the Mediterranean region and Central Asia but now cultivated worldwide. Its leaves are lemon-scented and used in teas, foods, herbal remedies, and cosmetics[1][3][4][5]. Lemon balm is traditionally recognized for effects such as reducing anxiety, improving sleep, aiding digestion, and managing symptoms of herpes infections[1][2][3][5]. Its pharmacological properties are mainly attributed to polyphenolic compounds, essential oils, and flavonoids, which have demonstrated antioxidant, antiviral, antispasmodic, and neuroprotective effects in preclinical and some clinical contexts[1][2][5]. However, it is not a molecular target—such as an enzyme, receptor, or transporter—but rather a source of active compounds that may act on diverse molecular targets within the body. Key Point: Lemon balm is a medicinal plant, not a defined therapeutic molecular target. Its bioactive compounds may influence various targets indirectly, but "lemon balm" itself is not a protein, receptor, or other canonical target recognized in molecular pharmacology[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Melissa officinalis.